p16(ink4) expression and spirometry tests have similar survival outcomes values in non-small-cell lung cancer patients

Edin Jusufovic (Tuzla, Bosnia and Herzegovina), Rifat Sejdinovic, Edin Jusufovic, Dragan Keser, Besim Prnjavorac, Ljiljana Sejdinovic, Azra Okanovic

Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Session: Lung cancer: prognostic factors and features of oncogene-driven tumours
Session type: Thematic Poster Session
Number: 4243
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Edin Jusufovic (Tuzla, Bosnia and Herzegovina), Rifat Sejdinovic, Edin Jusufovic, Dragan Keser, Besim Prnjavorac, Ljiljana Sejdinovic, Azra Okanovic. p16(ink4) expression and spirometry tests have similar survival outcomes values in non-small-cell lung cancer patients. Eur Respir J 2015; 46: Suppl. 59, 4243

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Possible predictors of the bronchodilation test response within lung function assessment of patients with operable lung cancer
Source: Eur Respir J 2005; 26: Suppl. 49, 326s
Year: 2005

Lung function testing for the preoperative evaluation of patients with lung cancer
Source: Annual Congress 2003 - Lung function testing for preoperative evaluation in lung cancer patients
Year: 2003


Comparing exhaled molecular profiles of patients with non-small cell lung cancer (NSCLC) with those of patients with non-pulmonary malignancy
Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease
Year: 2010

Does the lung function affect the survival time in patients with resected non-small cell lung cancer?
Source: Annual Congress 2007 - Lung function parameters before and after thoracic surgery
Year: 2007


Pulmonary function testing in patients with lung cancer
Source: Annual Congress 2012 - Instructive clinical aspects of thoracic oncology
Year: 2012

Cardiopulmonary exercise testing in patients with non-small cell lung cancer: maximality criteria analysis.
Source: Virtual Congress 2020 – Localised non-small cell lung cancer
Year: 2020


The evaluation of lung cancer patients
Source: Eur Respir J 2005; 26: Suppl. 49, 323s
Year: 2005

Factors associated with delayed recovery to predicted FEV1 calculated with perfusion scan in non-small-cell lung cancer patients after lobectomy
Source: International Congress 2017 – Lung cancer: important scientific reports from endoscopists and thoracic surgeons
Year: 2017

Utility of the 3-minute chair rise test (3CRT) to assess cardiopulmonary fitness of patients with non-small cell lung cancer before lung resection.
Source: Virtual Congress 2020 – Thoracic surgery: developments in diagnostics and outcomes
Year: 2020


Differences in the pattern of FEV1 and VC change after lung resection between lung cancer patients with limited and normal lung function
Source: Eur Respir J 2006; 28: Suppl. 50, 278s
Year: 2006

The utility of vibration response imaging for calculation of ppoFEV1 and ppoDL,CO in patients with lung cancer referred for resection – The influence of coexisting COPD
Source: Annual Congress 2013 –Lung surgery: preoperative assessment and postoperative outcome
Year: 2013



Correlation of quality of life parameters with parameters of health state in patients with nonsmall cell lung cancer treated by chemotherapy
Source: Eur Respir J 2003; 22: Suppl. 45, 30s
Year: 2003

Comparison of two methods for estimating the predicted postoperative (PPO) lung function after lung cancer resection in COPD patients
Source: Annual Congress 2009 - Preoperative functional assessment and surgery for malignant diseases
Year: 2009


Changes in lung function tests in lung carcinoma patients due to radiotherapy
Source: Eur Respir J 2001; 18: Suppl. 33, 221s
Year: 2001

Chemotherapy improves low performance status lung cancer patients
Source: Eur Respir J 2007; 30: 1186-1192
Year: 2007



Three-year spirometric evolution after lobectomy in lung cancer patients with or without COPD previous surgery
Source: International Congress 2016 – Clinical aspects of lung cancer
Year: 2016


Estimated postoperative pulmonary function and 6 months recovery for lobectomized lung cancer patients with and without COPD
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016

Lung function estimation in patients with lung cancer qualified for surgical treatment
Source: Eur Respir J 2006; 28: Suppl. 50, 719s
Year: 2006

Lung function assessment in octogenarians with lung cancer diagnosis
Source: International Congress 2017 – Thoracic surgery
Year: 2017

Treatment of patients with advanced non-small-cell lung cancer (NSCLC) with erlotinib: results from clinical practice
Source: Annual Congress 2008 - Therapy of thoracic tumours
Year: 2008